002693 *ST双成
已收盘 07-09 15:00:00
资讯
新帖
简况
*ST双成:公司没有收购计划,正积极采取措施争取撤销退市风险警示
证券之星 · 12:51
*ST双成:公司没有收购计划,正积极采取措施争取撤销退市风险警示
异动快报:*ST双成(002693)7月3日10点15分触及涨停板
证券之星 · 07-03
异动快报:*ST双成(002693)7月3日10点15分触及涨停板
异动快报:*ST双成(002693)6月13日14点45分触及跌停板
证券之星 · 06-13
异动快报:*ST双成(002693)6月13日14点45分触及跌停板
*ST双成最新公告:公司与Emerge Bioscience Pte. Ltd.达成《许可及供应协议》补充协议
证券之星 · 06-09
*ST双成最新公告:公司与Emerge Bioscience Pte. Ltd.达成《许可及供应协议》补充协议
异动快报:*ST双成(002693)6月5日13点52分触及跌停板
证券之星 · 06-05
异动快报:*ST双成(002693)6月5日13点52分触及跌停板
异动快报:*ST双成(002693)5月26日9点33分触及涨停板
证券之星 · 05-26
异动快报:*ST双成(002693)5月26日9点33分触及涨停板
每周股票复盘:*ST双成(002693)连续三次登上龙虎榜,依替巴肽注射液获澳大利亚上市许可
证券之星 · 05-23
每周股票复盘:*ST双成(002693)连续三次登上龙虎榜,依替巴肽注射液获澳大利亚上市许可
异动快报:*ST双成(002693)5月23日14点31分触及跌停板
证券之星 · 05-23
异动快报:*ST双成(002693)5月23日14点31分触及跌停板
【*ST双成:股票交易异常波动,连续三个交易日收盘价格涨幅偏离值累计超12%】金融界5月22日消息,*ST双成发布异动公告,公司股票交易价格于2025年5月20日、2025年5月21日及2025年5月22日连续三个交易日收盘价格涨幅偏离值累计超过12%,根据规定属于股票交易异常波动情况。公司曾因2024年度相关业绩指标问题被实施退市风险警示,近期注射用紫杉醇(白蛋白结合型)ANDA获美国FDA上市许可,已收到经销商订单申请并实现美国出口首次发货 。
金融界 · 05-22
【*ST双成:股票交易异常波动,连续三个交易日收盘价格涨幅偏离值累计超12%】金融界5月22日消息,*ST双成发布异动公告,公司股票交易价格于2025年5月20日、2025年5月21日及2025年5月22日连续三个交易日收盘价格涨幅偏离值累计超过12%,根据规定属于股票交易异常波动情况。公司曾因2024年度相关业绩指标问题被实施退市风险警示,近期注射用紫杉醇(白蛋白结合型)ANDA获美国FDA上市许可,已收到经销商订单申请并实现美国出口首次发货 。
5月22日*ST双成(002693)龙虎榜数据:机构净买入393.54万元(3日)
证券之星 · 05-22
5月22日*ST双成(002693)龙虎榜数据:机构净买入393.54万元(3日)
异动快报:*ST双成(002693)5月22日9点38分触及涨停板
证券之星 · 05-22
异动快报:*ST双成(002693)5月22日9点38分触及涨停板
异动快报:*ST双成(002693)5月21日9点53分触及涨停板
证券之星 · 05-21
异动快报:*ST双成(002693)5月21日9点53分触及涨停板
*ST双成(002693.SZ):依替巴肽注射液获得澳大利亚药物管理局(TGA)上市许可
智通财经 · 05-19
*ST双成(002693.SZ):依替巴肽注射液获得澳大利亚药物管理局(TGA)上市许可
*ST双成最新公告:依替巴肽注射液获得澳大利亚药物管理局上市许可
证券之星 · 05-19
*ST双成最新公告:依替巴肽注射液获得澳大利亚药物管理局上市许可
5月19日*ST双成(002693)龙虎榜数据:游资徐留胜上榜
证券之星 · 05-19
5月19日*ST双成(002693)龙虎榜数据:游资徐留胜上榜
*ST双成(002693.SZ):注射用紫杉醇(白蛋白结合型)ANDA获美国FDA上市许可
智通财经 · 05-16
*ST双成(002693.SZ):注射用紫杉醇(白蛋白结合型)ANDA获美国FDA上市许可
*ST双成:公司股票被实施退市风险警示
证券之星 · 05-15
*ST双成:公司股票被实施退市风险警示
异动快报:*ST双成(002693)5月14日14点33分触及跌停板
证券之星 · 05-14
异动快报:*ST双成(002693)5月14日14点33分触及跌停板
*ST双成:为争取撤销退市风险警示公司董事会正在积极主动采取措施
证券之星 · 05-13
*ST双成:为争取撤销退市风险警示公司董事会正在积极主动采取措施
异动快报:*ST双成(002693)5月12日13点26分触及涨停板
证券之星 · 05-12
异动快报:*ST双成(002693)5月12日13点26分触及涨停板
加载更多
公司概况
公司名称:
海南双成药业股份有限公司
所属行业:
医药制造业
上市日期:
2012-08-08
主营业务:
海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用胸腺法新、注射用比伐芦定、注射用生长抑素、依替巴肽注射液、醋酸奥曲肽注射液。公司现为国家高新技术企业,主导产品“基泰”药品质量和适应症与原研参比制剂一致,并已获得原研药注册地意大利药品管理局颁发的注射用胸腺法新(基泰)上市许可证,质量层次已达到和原研药同等的标准。
发行价格:
20.00
{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"*ST双成","latestPrice":7.37,"timestamp":1752044604000,"preClose":7.42,"halted":0,"volume":11186650,"delay":0,"changeRate":-0.0067,"floatShares":411000000,"shares":415000000,"eps":-0.192,"marketStatus":"已收盘","change":-0.05,"latestTime":"07-09 15:00:00","open":7.38,"high":7.47,"low":7.33,"amount":82591300,"amplitude":0.0189,"askPrice":7.38,"askSize":666,"bidPrice":7.37,"bidSize":1046,"shortable":0,"etf":0,"ttmEps":-0.192,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752111000000},"marketStatusCode":5,"adr":0,"adjPreClose":7.42,"symbolType":"stock","openAndCloseTimeList":[[1752024600000,1752031800000],[1752037200000,1752044400000]],"highLimit":7.79,"lowLimit":7.05,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":414689750,"isCdr":false,"pbRate":8.03,"roa":"--","roe":"--","epsLYR":-0.19,"committee":0.427824,"marketValue":3056000000,"turnoverRate":0.0272,"status":1,"floatMarketCap":3031000000},"requestUrl":"/m/hq/s/002693","defaultTab":"news","newsList":[{"id":"2550630540","title":"*ST双成:公司没有收购计划,正积极采取措施争取撤销退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2550630540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550630540?lang=zh_cn&edition=full","pubTime":"2025-07-09 20:51","pubTimestamp":1752065500,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST双成07月08日在投资者关系平台上答复投资者关心的问题。*ST双成回复:尊敬的投资者您好,截止目前公司没有收购计划。为争取撤销退市风险警示,公司董事会正在积极主动采取措施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070900036241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2548840000","title":"异动快报:*ST双成(002693)7月3日10点15分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2548840000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548840000?lang=zh_cn&edition=full","pubTime":"2025-07-03 10:15","pubTimestamp":1751508928,"startTime":"0","endTime":"0","summary":"证券之星7月3日盘中消息,10点15分*ST双成触及涨停板。目前价格7.73,上涨5.03%。其所属行业化学制药目前上涨。领涨股为诚意药业。该股为阿尔茨海默病,肝炎概念,医药概念热股,当日阿尔茨海默病概念上涨2.11%,肝炎概念概念上涨1.87%,医药概念上涨1.22%。7月2日的资金流向数据方面,主力资金净流出1215.99万元,占总成交额13.39%,游资资金净流出170.73万元,占总成交额1.88%,散户资金净流入1386.73万元,占总成交额15.27%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300010907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2543157704","title":"异动快报:*ST双成(002693)6月13日14点45分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2543157704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543157704?lang=zh_cn&edition=full","pubTime":"2025-06-13 14:50","pubTimestamp":1749797434,"startTime":"0","endTime":"0","summary":"证券之星6月13日盘中消息,14点45分*ST双成(002693)触及跌停板。目前价格7.46,下跌4.97%。其所属行业化学制药目前下跌。领涨股为永安药业。该股为国产芯片,海南概念,半导体概念热股。6月13日的资金流向数据方面,主力资金净流出1343.96万元,占总成交额12.12%,游资资金净流出154.02万元,占总成交额1.39%,散户资金净流入1497.97万元,占总成交额13.51%。近5日资金流向一览见下表:*ST双成主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061300016638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2542802164","title":"*ST双成最新公告:公司与Emerge Bioscience Pte. Ltd.达成《许可及供应协议》补充协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2542802164","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542802164?lang=zh_cn&edition=full","pubTime":"2025-06-09 17:16","pubTimestamp":1749460605,"startTime":"0","endTime":"0","summary":"*ST双成(002693.SZ)公告称,公司与Meitheal Pharmaceuticals, Inc.和Hong Kong King -Friend Industrial Co., Ltd.签署的《许可及供应协议》达成补充协议,合同履约主体由Meitheal变更为Emerge Bioscience Pte. Ltd.,Emerge将承担Meitheal在协议中所承担的所有责任和义务。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900022036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2541043544","title":"异动快报:*ST双成(002693)6月5日13点52分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2541043544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541043544?lang=zh_cn&edition=full","pubTime":"2025-06-05 13:55","pubTimestamp":1749102922,"startTime":"0","endTime":"0","summary":"证券之星6月5日盘中消息,13点52分*ST双成触及跌停板。目前价格8.09,下跌5.05%。其所属行业化学制药目前下跌。领涨股为亚太药业。该股为半导体,国产芯片,海南概念概念热股,当日半导体概念上涨1.35%,国产芯片概念上涨1.13%。6月5日的资金流向数据方面,主力资金净流出1712.78万元,占总成交额10.73%,游资资金净流出326.67万元,占总成交额2.05%,散户资金净流入2039.45万元,占总成交额12.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060500015101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2538422771","title":"异动快报:*ST双成(002693)5月26日9点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2538422771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538422771?lang=zh_cn&edition=full","pubTime":"2025-05-26 09:36","pubTimestamp":1748223365,"startTime":"0","endTime":"0","summary":"证券之星5月26日盘中消息,9点33分*ST双成触及涨停板。目前价格8.56,上涨5.03%。其所属行业化学制药目前上涨。领涨股为新天地。该股为半导体,国产芯片,海南概念概念热股,当日半导体概念上涨0.78%,国产芯片概念上涨0.57%。5月23日的资金流向数据方面,主力资金净流出2204.04万元,占总成交额5.2%,游资资金净流出460.02万元,占总成交额1.08%,散户资金净流入2664.07万元,占总成交额6.28%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052600003945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2537157715","title":"每周股票复盘:*ST双成(002693)连续三次登上龙虎榜,依替巴肽注射液获澳大利亚上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2537157715","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537157715?lang=zh_cn&edition=full","pubTime":"2025-05-24 05:33","pubTimestamp":1748035995,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,*ST双成报收于8.15元,较上周的7.06元上涨15.44%。本周,*ST双成5月22日盘中最高价报8.58元。这是近5个交易日内第二次上榜。公司公告汇总海南双成药业股份有限公司近日收到澳大利亚药物管理局签发的依替巴肽注射液的上市许可。公司注射用紫杉醇ANDA获得美国FDA上市许可批准,并已实现美国出口首次发货。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400008525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2537904914","title":"异动快报:*ST双成(002693)5月23日14点31分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2537904914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537904914?lang=zh_cn&edition=full","pubTime":"2025-05-23 14:35","pubTimestamp":1747982129,"startTime":"0","endTime":"0","summary":"证券之星5月23日盘中消息,14点31分*ST双成触及跌停板。目前价格8.15,下跌5.01%。其所属行业化学制药目前上涨。领涨股为海辰药业。该股为医药,肝炎概念,阿尔茨海默病概念热股,当日医药概念上涨1.24%,肝炎概念概念上涨0.81%,阿尔茨海默病概念上涨0.79%。5月23日的资金流向数据方面,主力资金净流出674.23万元,占总成交额2.35%,游资资金净流出462.02万元,占总成交额1.61%,散户资金净流入1136.25万元,占总成交额3.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300017324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2537943690","title":"【*ST双成:股票交易异常波动,连续三个交易日收盘价格涨幅偏离值累计超12%】金融界5月22日消息,*ST双成发布异动公告,公司股票交易价格于2025年5月20日、2025年5月21日及2025年5月22日连续三个交易日收盘价格涨幅偏离值累计超过12%,根据规定属于股票交易异常波动情况。公司曾因2024年度相关业绩指标问题被实施退市风险警示,近期注射用紫杉醇(白蛋白结合型)ANDA获美国FDA上市许可,已收到经销商订单申请并实现美国出口首次发货 。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537943690","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537943690?lang=zh_cn&edition=full","pubTime":"2025-05-22 19:27","pubTimestamp":1747913246,"startTime":"0","endTime":"0","summary":"金融界5月22日消息,*ST双成发布异动公告,公司股票交易价格于2025年5月20日、2025年5月21日及2025年5月22日连续三个交易日收盘价格涨幅偏离值累计超过12%,根据规定属于股票交易异常波动情况。公司曾因2024年度相关业绩指标问题被实施退市风险警示,近期注射用紫杉醇(白蛋白结合型)ANDA获美国FDA上市许可,已收到经销商订单申请并实现美国出口首次发货 。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/22192750597204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2537143919","title":"5月22日*ST双成(002693)龙虎榜数据:机构净买入393.54万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2537143919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537143919?lang=zh_cn&edition=full","pubTime":"2025-05-22 17:21","pubTimestamp":1747905683,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年5月22日公布的交易公开信息显示,*ST双成因连续三个交易日内,涨幅偏离值累计达到12%的ST证券、*ST证券和未完成股改证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年5月22日收盘,*ST双成报收于8.58元,上涨5.02%,换手率15.55%,成交量63.96万手,成交额5.46亿元。从龙虎榜公布的三日买卖数据来看,机构合计净买入393.54万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200026575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2537969375","title":"异动快报:*ST双成(002693)5月22日9点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2537969375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537969375?lang=zh_cn&edition=full","pubTime":"2025-05-22 09:40","pubTimestamp":1747878043,"startTime":"0","endTime":"0","summary":"证券之星5月22日盘中消息,9点38分*ST双成触及涨停板。目前价格8.58,上涨5.02%。其所属行业化学制药目前下跌。领涨股为*ST赛隆。该股为半导体,肝炎概念,国产芯片概念热股,当日半导体概念上涨0.07%。5月21日的资金流向数据方面,主力资金净流出42.21万元,占总成交额0.19%,游资资金净流入119.38万元,占总成交额0.54%,散户资金净流出77.17万元,占总成交额0.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200007144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2537167304","title":"异动快报:*ST双成(002693)5月21日9点53分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2537167304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537167304?lang=zh_cn&edition=full","pubTime":"2025-05-21 09:55","pubTimestamp":1747792523,"startTime":"0","endTime":"0","summary":"证券之星5月21日盘中消息,9点53分*ST双成触及涨停板。目前价格8.17,上涨5.01%。其所属行业化学制药目前上涨。领涨股为舒泰神。该股为医药,阿尔茨海默病,肝炎概念概念热股,当日医药概念上涨1.06%,阿尔茨海默病概念上涨0.96%,肝炎概念概念上涨0.94%。5月20日的资金流向数据方面,主力资金净流入563.35万元,占总成交额43.82%,游资资金净流出208.19万元,占总成交额16.2%,散户资金净流出355.16万元,占总成交额27.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100008845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2536064507","title":"*ST双成(002693.SZ):依替巴肽注射液获得澳大利亚药物管理局(TGA)上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2536064507","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536064507?lang=zh_cn&edition=full","pubTime":"2025-05-19 17:52","pubTimestamp":1747648363,"startTime":"0","endTime":"0","summary":"智通财经APP讯,*ST双成(002693.SZ)发布公告,公司于近日收到澳大利亚药物管理局(TGA)签发的依替巴肽注射液的上市许可。获批适应症:适用于接受非紧急经皮冠状动脉介入治疗并进行冠状动脉内支架植入的患者;适用于治疗不稳定性心绞痛或非Q波型心肌梗死患者。本次依替巴肽注射液获得澳大利亚药物管理局签发的上市许可,表明公司依替巴肽注射液具备了在澳大利亚进行销售的资质。对公司拓展海外市场、提升公司业绩带来积极的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1294843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"*ST双成(002693.SZ):依替巴肽注射液获得澳大利亚药物管理局(TGA)上市许可","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4213","TGA","002693"],"gpt_icon":0},{"id":"2536502561","title":"*ST双成最新公告:依替巴肽注射液获得澳大利亚药物管理局上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2536502561","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536502561?lang=zh_cn&edition=full","pubTime":"2025-05-19 17:30","pubTimestamp":1747647057,"startTime":"0","endTime":"0","summary":"*ST双成(002693.SZ)公告称,公司于近日收到澳大利亚药物管理局签发的依替巴肽注射液的上市许可。该药品适用于接受非紧急经皮冠状动脉介入治疗并进行冠状动脉内支架植入的患者,以及治疗不稳定性心绞痛或非Q波型心肌梗死患者。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051900023681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2536501797","title":"5月19日*ST双成(002693)龙虎榜数据:游资徐留胜上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2536501797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536501797?lang=zh_cn&edition=full","pubTime":"2025-05-19 17:20","pubTimestamp":1747646448,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年5月19日公布的交易公开信息显示,*ST双成因连续三个交易日内,涨幅偏离值累计达到12%的ST证券、*ST证券和未完成股改证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年5月19日收盘,*ST双成报收于7.41元,上涨4.96%,换手率0.86%,成交量3.52万手,成交额2611.43万元。从龙虎榜公布的三日买卖数据来看,徐留胜等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051900023239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2535412366","title":"*ST双成(002693.SZ):注射用紫杉醇(白蛋白结合型)ANDA获美国FDA上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2535412366","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535412366?lang=zh_cn&edition=full","pubTime":"2025-05-16 17:24","pubTimestamp":1747387483,"startTime":"0","endTime":"0","summary":"智通财经APP讯,*ST双成 公告,公司近日收到美国食品和药品监督管理局的通知,公司向美国FDA提交的注射用紫杉醇简略新药申请已获得美国FDA的上市许可批准。美国FDA对公司递交的注射用紫杉醇ANDA申报资料进行了全面技术审评,认定公司的产品与原研药品生物等效和疗效等效。此外,注射用紫杉醇可在肿瘤中产生积蓄,定向释放至肿瘤细胞,具有靶向性,进一步提高药物的疗效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1294150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"*ST双成(002693.SZ):注射用紫杉醇(白蛋白结合型)ANDA获美国FDA上市许可","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2535806828","title":"*ST双成:公司股票被实施退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2535806828","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535806828?lang=zh_cn&edition=full","pubTime":"2025-05-15 20:51","pubTimestamp":1747313465,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST双成05月14日在投资者关系平台上答复投资者关心的问题。投资者提问:ST双成002693会不会退市?*ST双成回复:尊敬的投资者,感谢您的关注。公司2024年度经审计的财务指标触及《深圳证券交易所股票上市规则》第9.3.1条第一款规定的情形,公司股票被实施退市风险警示。敬请广大投资者理性投资,注意投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051500034988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2535995110","title":"异动快报:*ST双成(002693)5月14日14点33分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2535995110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535995110?lang=zh_cn&edition=full","pubTime":"2025-05-14 14:35","pubTimestamp":1747204525,"startTime":"0","endTime":"0","summary":"证券之星5月14日盘中消息,14点33分*ST双成(002693)触及跌停板。目前价格6.56,下跌4.93%。其所属行业化学制药目前下跌。领涨股为永安药业。该股为海南概念,医药,国产芯片概念热股。5月14日的资金流向数据方面,主力资金净流出398.66万元,占总成交额2.28%,游资资金净流出967.48万元,占总成交额5.54%,散户资金净流入1366.13万元,占总成交额7.82%。近5日资金流向一览见下表:*ST双成主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051400018639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2535737947","title":"*ST双成:为争取撤销退市风险警示公司董事会正在积极主动采取措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2535737947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535737947?lang=zh_cn&edition=full","pubTime":"2025-05-13 20:51","pubTimestamp":1747140692,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST双成05月12日在投资者关系平台上答复投资者关心的问题。*ST双成回复:尊敬的投资者,感谢您的关注。研发、生产方面:积极推进在审品种的获批及ANDA在美国、加拿大和其它国家申报。敬请广大投资者理性投资,注意投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300036121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2534296395","title":"异动快报:*ST双成(002693)5月12日13点26分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2534296395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534296395?lang=zh_cn&edition=full","pubTime":"2025-05-12 13:30","pubTimestamp":1747027842,"startTime":"0","endTime":"0","summary":"证券之星5月12日盘中消息,13点26分*ST双成触及涨停板。目前价格7.28,上涨5.05%。其所属行业化学制药目前下跌。领涨股为通化金马。该股为国产芯片,半导体,海南概念概念热股,当日国产芯片概念上涨1.31%,半导体概念上涨1.11%,海南概念概念上涨0.41%。5月12日的资金流向数据方面,主力资金净流入499.61万元,占总成交额2.48%,游资资金净流出212.09万元,占总成交额1.05%,散户资金净流出287.52万元,占总成交额1.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051200013101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752083020060,"stockEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":-0.1216},{"period":"3month","weight":-0.0706},{"period":"6month","weight":-0.5151},{"period":"1year","weight":0.706},{"period":"ytd","weight":-0.5979}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0274},{"period":"3month","weight":0.0836},{"period":"6month","weight":0.1024},{"period":"1year","weight":0.1803},{"period":"ytd","weight":0.0422}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"79029人(较上一季度减少6.42%)","perCapita":"5203股","listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","registeredCapital":"41468万元","survey":" 海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用胸腺法新、注射用比伐芦定、注射用生长抑素、依替巴肽注射液、醋酸奥曲肽注射液。公司现为国家高新技术企业,主导产品“基泰”药品质量和适应症与原研参比制剂一致,并已获得原研药注册地意大利药品管理局颁发的注射用胸腺法新(基泰)上市许可证,质量层次已达到和原研药同等的标准。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST双成(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST双成(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST双成,002693,*ST双成股票,*ST双成股票老虎,*ST双成股票老虎国际,*ST双成行情,*ST双成股票行情,*ST双成股价,*ST双成股市,*ST双成股票价格,*ST双成股票交易,*ST双成股票购买,*ST双成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST双成(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST双成(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}